Recent Quarter Total Invested
$24,788
Recent Quarter Institutional Ownership Percentage
0.79%
Total Invested of Last Quarter
$99,045
Ownership Percentage of Last Quarter
1.53%
NeuroSense Therapeutics Ltd. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| CLEAR STREET LLC | 08/12/2024 | 59,272 | $12,000 | 0.17% | 0.38% |
| WARBERG ASSET MANAGEMENT LLC | 08/09/2024 | 32,006 | $6,593 | -22.70% | 0.21% |
| CITADEL ADVISORS LLC | 08/14/2024 | 29,464 | $6,070 | -38.79% | 0.19% |
| UBS GROUP AG | 08/14/2024 | 605 | $125 | 100.00% | 0.00% |
| HUDSON BAY CAPITAL MANAGEMENT LP | 08/14/2024 | 0 | $0 | -100.00% | 0.00% |
NeuroSense Therapeutics Ltd.institutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of NRSNW shares?
During the previous two years, 5 institutional investors and hedge funds held shares of NeuroSense Therapeutics Ltd.. The most heavily invested institutionals were:
CLEAR STREET LLC: 65,759
CITADEL ADVISORS LLC: 25,274
Warberg Asset Management LLC: 20,201
UBS Group AG: 200
Empery Asset Management, LP: 160,000
-
What percentage of NeuroSense Therapeutics Ltd. stock is owned by institutional investors?
0.79% of NeuroSense Therapeutics Ltd. stock is owned by institutional investors.
-
How much institutional buying is happening at NRSNW ?
Institutional investors have bought a total of 271,434 shares in the last 24 months. This purchase volume represents approximately $70,573 in transactions.